Member Info for mikelma10

Showing no trades and MMs happy to let the price sit there. Me thinks there is something being worked in the background.

I assume the rise today was because of the news on AI drug discovery. Either that or other news incoming.

https://www.dailymail.co.uk/money/investing/article-11745243/SMALL-CAP-IDEAS-small-drug-firms-set-benefit-RSV-vaccines.html

To be honest it's been pretty dark for a few months now, but there's light at the end of the tunnel for this great company. Amryt delisted from AIM last year, and who can blame them. The sooner we get on NASDAQ the better.

Currently 9.98 on the Ask and 9.86 on the Bid. There is also a 500k @ 9.70 and a couple of +60k bids @ around 9.9 yet to be reported too.

Of course not! And this from someone who's just lost >30% on TGP in less than a week. Thanks for the advice.

If you look at IG L2, all of these are Buys. ~15.85p to Buy, ~15.75p to Sell.

Simple answer is yes. Its a matter of time. and depends on three things. Revenue, Profit and Spin Offs.
Revenue can improve by either increasing the price of of the service, or increasing the capacity/services by adding more facilities.
Profit will improve by reducing costs or increasing prices
Spin Offs will offer a dividend in specie or add to revenue/profit if OO retains a holding in the new company
Nice to hear that OO is focussing on long term growth and sustainable revenue, but this will take time. I don't think will see a runaway share price that we saw last year (unless there is something new that comes out of the blue). I downsized a lot here but will look to reinvest when confidence returns, and it will.

You can choose who to filter here. https://www.lse.co.uk/ShareChat.asp?ShareTicker=ORPH&share=Open-Orphan

Did anyone else see the news that "QuantBioRes is developing a peptide, which inhibits the coronavirus from infecting a human cell. It expects to launch clinical trials in the UK this summer."? Great opportunity to use OO CHIM model.

Does anyone know what the story is behind this RNS? Clem founded Online Blockchain PLC and along with other Directors hold 17.63% of ADVFN. Is this an attempt at a management buyout, to prevent an hostile takeover by the Israeli contingent? Will there be a bidding war now? What are everyone's thoughts on this?

In all my years following Orph (and previously Hvivo) this is the single most strangest day in terms of trading patterns that I have seen. Very large volume of trades. Going down when it looked like it should be going up, and vice versa. Something must be going on in the background. Maybe after the day will tell us what is going on.

Don' be fooled by the red and blue. Most of the sells are buys. Currently best price to sell is 20.155 and best for buy is 20.65. It's being reported all wrong most of the morning. Someone is loading up on OO.

Orc. I think we've booked around £45m in revenue for this year, approx 90% of capacity. 3x revenue would be £135m MCap, pretty much where we are. There are also questions over margins, although the expectation is that these will be better than last year. Without new revenue streams we'll languish here and be a target for traders, rather than investors. New Covid contracts, or increase in capacity would help. Everything else is just noise. I wouldn't pin hopes on the spin outs, as these are zero value to OO, unless OO retains some % in them, and will have to survive on their own (they may yet yield a windfall for shareholders at some time in the future) . My concern is that it's taking so long to monetise the remaining non-service assets, that they'll be redundant by the time we get around to it, and have a fraction of the value they would have last year. A buy-out seems attractive right now, for the right price of course. It's the only way CF will see the highest return for his large stake in OO.

Si. Best graphic of the year award goes to you. Fancy a job in PR at OO?

Only 5k left at 23p on RSP, can't get a quote for anything else.

There's a lot of negativity on the board for what has been a good day for the SP. Someone saying the 3x revenue is too high, when the industry norm is around 3.4x for a steady pharma service company, not one that has product assets to spin out and other growth opportunities. You might as well say 7x or 10x revenue for OO. No one knows, but the market will determine the SP not naysayers on this board.

Just sold 110,000 for 19.125 and bought back 50.000 for 19.075. Why is it cheaper to buy than sell?

Well his credentials for paying taxes may be a little poor, but he knows how to make money investing. Interesting times to come.

If you want the true picture use IG L2. You can see the retail prices there. Currently 19.975 is the best price for "Buys" and 19.7601 the best price for "Sells". So lots of buying at the moment.